TrialDiabetologia2019

Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study.

Robert S Rosenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.